VBIV Annual SG&A
$42.14 M
-$13.98 M-24.91%
31 December 2023
Summary:
As of January 28, 2025, VBIV annual selling, general & administrative expenses is $42.14 million, with the most recent change of -$13.98 million (-24.91%) on December 31, 2023. During the last 3 years, it has risen by +$21.49 million (+104.07%).VBIV Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly SG&A
$7.67 M
-$1.24 M-13.87%
31 March 2024
Summary:
As of January 28, 2025, VBIV quarterly selling, general & administrative expenses is $7.67 million, with the most recent change of -$1.24 million (-13.87%) on March 31, 2024. Over the past year, it has dropped by -$3.25 million (-29.73%).VBIV Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM SG&A
-$2.33 B
-$82.98 M-3.70%
31 March 2024
Summary:
As of January 28, 2025, VBIV TTM selling, general & administrative expenses is -$2.33 billion, with the most recent change of -$82.98 million (-3.70%) on March 31, 2024. Over the past year, it has dropped by -$2.38 billion (-4385.29%).VBIV TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.9% | -29.7% | -4385.3% |
| 3 y3 years | +104.1% | -51.7% | -4246.9% |
| 5 y5 years | +105.5% | -51.7% | -4246.9% |
VBIV Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -24.9% | -51.7% | -4079.9% |
VBI Vaccines Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $7.67 M(-13.9%) | $36.53 M(-13.3%) |
| Dec 2023 | $42.14 M(-24.9%) | $8.91 M(-1.4%) | $42.14 M(-14.2%) |
| Sept 2023 | - | $9.04 M(-17.2%) | $49.12 M(-9.5%) |
| June 2023 | - | $10.92 M(-17.8%) | $54.31 M(-7.1%) |
| Mar 2023 | - | $13.28 M(-16.4%) | $58.47 M(+4.2%) |
| Dec 2022 | $56.12 M(+46.4%) | $15.89 M(+11.7%) | $56.12 M(+6.4%) |
| Sept 2022 | - | $14.22 M(-5.7%) | $52.76 M(+9.4%) |
| June 2022 | - | $15.08 M(+38.0%) | $48.23 M(+13.4%) |
| Mar 2022 | - | $10.93 M(-12.8%) | $42.52 M(+10.9%) |
| Dec 2021 | $38.34 M(+85.6%) | $12.53 M(+29.2%) | $38.34 M(+16.4%) |
| Sept 2021 | - | $9.69 M(+3.5%) | $32.94 M(+14.3%) |
| June 2021 | - | $9.37 M(+38.8%) | $28.81 M(+23.4%) |
| Mar 2021 | - | $6.75 M(-5.4%) | $23.34 M(+13.0%) |
| Dec 2020 | $20.65 M(+46.5%) | $7.13 M(+28.2%) | $20.65 M(+87.0%) |
| Sept 2020 | - | $5.56 M(+42.6%) | $11.04 M(-25.9%) |
| June 2020 | - | $3.90 M(-3.9%) | $14.89 M(+5.0%) |
| Mar 2020 | - | $4.06 M(-263.8%) | $14.19 M(+0.7%) |
| Dec 2019 | $14.09 M(-31.3%) | -$2.48 M(-126.3%) | $14.09 M(-46.2%) |
| Sept 2019 | - | $9.41 M(+194.7%) | $26.17 M(+29.2%) |
| June 2019 | - | $3.19 M(-19.3%) | $20.25 M(-3.8%) |
| Mar 2019 | - | $3.96 M(-58.8%) | $21.05 M(+2.6%) |
| Dec 2018 | $20.51 M(+70.4%) | $9.61 M(+175.0%) | $20.51 M(+43.1%) |
| Sept 2018 | - | $3.49 M(-12.4%) | $14.33 M(+5.1%) |
| June 2018 | - | $3.99 M(+16.4%) | $13.63 M(+9.8%) |
| Mar 2018 | - | $3.42 M(+0.1%) | $12.41 M(+3.2%) |
| Dec 2017 | $12.03 M(+2.3%) | $3.42 M(+22.5%) | $12.03 M(-0.6%) |
| Sept 2017 | - | $2.79 M(+0.9%) | $12.11 M(-2.8%) |
| June 2017 | - | $2.77 M(-9.0%) | $12.46 M(-2.9%) |
| Mar 2017 | - | $3.04 M(-12.9%) | $12.83 M(+9.1%) |
| Dec 2016 | $11.76 M(+72.0%) | $3.49 M(+11.0%) | $11.76 M(+10.6%) |
| Sept 2016 | - | $3.15 M(+0.4%) | $10.64 M(+5.2%) |
| June 2016 | - | $3.14 M(+58.5%) | $10.11 M(+34.2%) |
| Mar 2016 | - | $1.98 M(-16.5%) | $7.53 M(+24.7%) |
| Dec 2015 | $6.84 M(+157.9%) | $2.37 M(-9.6%) | $6.04 M(+28.2%) |
| Sept 2015 | - | $2.62 M(+368.9%) | $4.71 M(+76.5%) |
| June 2015 | - | $559.00 K(+14.4%) | $2.67 M(-2.0%) |
| Mar 2015 | - | $488.70 K(-53.0%) | $2.72 M(+4.1%) |
| Mar 2015 | $2.65 M(+86.9%) | - | - |
| Dec 2014 | - | $1.04 M(+79.4%) | $2.62 M(+38.2%) |
| Sept 2014 | - | $580.20 K(-5.4%) | $1.89 M(+9.1%) |
| June 2014 | - | $613.40 K(+60.5%) | $1.74 M(+21.0%) |
| Mar 2014 | $1.42 M(-41.2%) | $382.20 K(+20.2%) | $1.43 M(+32.7%) |
| Dec 2013 | - | $317.90 K(-24.8%) | $1.08 M(-13.5%) |
| Sept 2013 | - | $422.50 K(+35.3%) | $1.25 M(-43.9%) |
| June 2013 | - | $312.30 K(+980.6%) | $2.23 M(-7.7%) |
| Mar 2013 | $2.41 M(+8.5%) | $28.90 K(-94.1%) | $2.42 M(+1.2%) |
| Dec 2012 | - | $486.70 K(-65.3%) | $2.39 M(-6.5%) |
| Sept 2012 | - | $1.40 M(+180.8%) | $2.55 M(-43.7%) |
| June 2012 | - | $499.10 K(>+9900.0%) | $4.54 M(-43.8%) |
| Mar 2012 | $2.22 M | $1200.00(-99.8%) | $8.08 M(-61.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | $652.30 K(-80.7%) | $20.97 M(-0.4%) |
| Sept 2011 | - | $3.39 M(-16.0%) | $21.05 M(-0.8%) |
| June 2011 | - | $4.03 M(-68.7%) | $21.22 M(+14.7%) |
| Mar 2011 | $17.28 M(+2261.9%) | $12.89 M(+1646.3%) | $18.51 M(+207.9%) |
| Dec 2010 | - | $738.30 K(-79.2%) | $6.01 M(+10.7%) |
| Sept 2010 | - | $3.55 M(+168.9%) | $5.43 M(+177.2%) |
| June 2010 | - | $1.32 M(+232.6%) | $1.96 M(+171.8%) |
| Mar 2010 | $731.60 K(+183.3%) | $397.30 K(+150.7%) | $720.80 K(+85.1%) |
| Dec 2009 | - | $158.50 K(+94.0%) | $389.40 K(+31.9%) |
| Sept 2009 | - | $81.70 K(-1.9%) | $295.20 K(-2.4%) |
| June 2009 | - | $83.30 K(+26.4%) | $302.50 K(+8.2%) |
| Mar 2009 | $258.20 K(-55.2%) | $65.90 K(+2.5%) | $279.70 K(-25.0%) |
| Dec 2008 | - | $64.30 K(-27.8%) | $372.70 K(-20.6%) |
| Sept 2008 | - | $89.00 K(+47.1%) | $469.50 K(-18.0%) |
| June 2008 | - | $60.50 K(-61.9%) | $572.50 K(-3.1%) |
| Mar 2008 | $576.00 K(+60.5%) | $158.90 K(-1.4%) | $590.60 K(+3.2%) |
| Dec 2007 | - | $161.10 K(-16.1%) | $572.20 K(+20.9%) |
| Sept 2007 | - | $192.00 K(+144.3%) | $473.40 K(+26.5%) |
| June 2007 | - | $78.60 K(-44.1%) | $374.20 K(+2.3%) |
| Mar 2007 | $358.80 K(-13.5%) | $140.50 K(+125.5%) | $365.80 K(-28.9%) |
| Dec 2006 | - | $62.30 K(-32.9%) | $514.80 K(+5.5%) |
| Sept 2006 | - | $92.80 K(+32.2%) | $488.10 K(+10.3%) |
| June 2006 | - | $70.20 K(-75.8%) | $442.50 K(+6.9%) |
| Mar 2006 | $414.70 K(+206.3%) | $289.50 K(+713.2%) | $413.90 K(+118.2%) |
| Dec 2005 | - | $35.60 K(-24.6%) | $189.70 K(+11.1%) |
| Sept 2005 | - | $47.20 K(+13.5%) | $170.80 K(+18.0%) |
| June 2005 | - | $41.60 K(-36.3%) | $144.80 K(+16.4%) |
| Mar 2005 | $135.40 K(+2.4%) | $65.30 K(+291.0%) | $124.40 K(+49.2%) |
| Dec 2004 | - | $16.70 K(-21.2%) | $83.40 K(-26.0%) |
| Sept 2004 | - | $21.20 K(0.0%) | $112.70 K(-7.3%) |
| June 2004 | - | $21.20 K(-12.8%) | $121.60 K(-6.3%) |
| Mar 2004 | $132.20 K(+61.2%) | $24.30 K(-47.2%) | $129.80 K(-10.5%) |
| Dec 2003 | - | $46.00 K(+52.8%) | $145.10 K(+34.2%) |
| Sept 2003 | - | $30.10 K(+2.4%) | $108.10 K(+11.4%) |
| June 2003 | - | $29.40 K(-25.8%) | $97.00 K(+24.0%) |
| Mar 2003 | $82.00 K(+15.5%) | $39.60 K(+340.0%) | $78.20 K(+12.2%) |
| Dec 2002 | - | $9000.00(-52.6%) | $69.70 K(-3.1%) |
| Sept 2002 | - | $19.00 K(+79.2%) | $71.90 K(+13.1%) |
| June 2002 | - | $10.60 K(-65.9%) | $63.60 K(-11.7%) |
| Mar 2002 | $71.00 K(+3.2%) | $31.10 K(+177.7%) | $72.00 K(+76.0%) |
| Dec 2001 | - | $11.20 K(+4.7%) | $40.90 K(-21.2%) |
| Sept 2001 | - | $10.70 K(-43.7%) | $51.90 K(-19.4%) |
| June 2001 | - | $19.00 K(-14.4%) | $64.40 K(+42.5%) |
| Dec 2000 | - | $22.20 K(-4.3%) | $45.20 K(+96.5%) |
| Sept 2000 | - | $23.20 K(<-9900.0%) | $23.00 K(-66.1%) |
| Mar 2000 | $68.80 K(-48.1%) | -$200.00(-100.3%) | $67.90 K(-49.9%) |
| Sept 1999 | - | $68.10 K(+0.9%) | $135.60 K(+2.0%) |
| Mar 1999 | $132.50 K(-6.0%) | $67.50 K(+3.1%) | $133.00 K(-2.6%) |
| Sept 1998 | - | $65.50 K(-7.7%) | $136.50 K(+92.3%) |
| Mar 1998 | $140.90 K(-2.8%) | $71.00 K | $71.00 K |
| Mar 1997 | $144.90 K | - | - |
FAQ
- What is VBI Vaccines annual selling, general & administrative expenses?
- What is the all time high annual SG&A for VBI Vaccines?
- What is VBI Vaccines annual SG&A year-on-year change?
- What is VBI Vaccines quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for VBI Vaccines?
- What is VBI Vaccines quarterly SG&A year-on-year change?
- What is VBI Vaccines TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for VBI Vaccines?
- What is VBI Vaccines TTM SG&A year-on-year change?
What is VBI Vaccines annual selling, general & administrative expenses?
The current annual SG&A of VBIV is $42.14 M
What is the all time high annual SG&A for VBI Vaccines?
VBI Vaccines all-time high annual selling, general & administrative expenses is $56.12 M
What is VBI Vaccines annual SG&A year-on-year change?
Over the past year, VBIV annual selling, general & administrative expenses has changed by -$13.98 M (-24.91%)
What is VBI Vaccines quarterly selling, general & administrative expenses?
The current quarterly SG&A of VBIV is $7.67 M
What is the all time high quarterly SG&A for VBI Vaccines?
VBI Vaccines all-time high quarterly selling, general & administrative expenses is $15.89 M
What is VBI Vaccines quarterly SG&A year-on-year change?
Over the past year, VBIV quarterly selling, general & administrative expenses has changed by -$3.25 M (-29.73%)
What is VBI Vaccines TTM selling, general & administrative expenses?
The current TTM SG&A of VBIV is -$2.33 B
What is the all time high TTM SG&A for VBI Vaccines?
VBI Vaccines all-time high TTM selling, general & administrative expenses is $58.47 M
What is VBI Vaccines TTM SG&A year-on-year change?
Over the past year, VBIV TTM selling, general & administrative expenses has changed by -$2.38 B (-4385.29%)